Format

Send to

Choose Destination
Gynecol Obstet Fertil. 2012 Dec;40(12):784-6. doi: 10.1016/j.gyobfe.2012.09.005. Epub 2012 Oct 25.

[Prenatal diethylstilbestrol exposure and breast cancer].

[Article in French]

Author information

1
Unité de sénologie, pôle de gynécologie-obstétrique, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France. severine.frigo@chru-strasbourg.fr

Abstract

Diethylstilbestrol (DES) is a synthetic estrogen prescribed to prevent miscarriages until 1977. Its role in the development of vaginal adenocarcinoma and cervical dysplasia is known and screening codified. Recent cohort studies show that exposure to DES in utero increases breast cancer risk especially after 40 years. This article reports the observation of a breast cancer of exceptional gravity in a patient exposed to DES in utero. It details the risk of breast cancer for "DES daughters" and support possible screening modalities.

PMID:
23102737
DOI:
10.1016/j.gyobfe.2012.09.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center